Ratings by Rodman & Renshaw
| Date | Analyst | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|---|
| 8/31/2026 | Michael King Jr. | QNTM | New Coverage | Buy (N/A) |
8.00 (N/A) |
3.08 (3.24) |
5.19% | Details | |
| 7/30/2026 | Michael King Jr. | Actuate Therapeutics | ACTU | New Coverage | Buy (N/A) |
6.00 (N/A) |
1.08 (1.48) |
37.04% | Details |
 |
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
| 83 more... | |||||||||
